-
Je něco špatně v tomto záznamu ?
Prevalence of drug use before and during imprisonment in seven European countries (2014-2018)
L. Montanari, L. Royuela, S. Mazzilli, L. Vandam, E. Alvarez, N. Llorens, L. Carapinha, K. Grohmannova, L. Isajeva, L. Ignataviciute, I. Kvaternik, J. Sierosławski, A. Malczewski, E. Plettinckx, R. Sendino, A. Torres, I. Yasemi, L. Tavoschi, V. Mravcik
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
37172289
DOI
10.1002/jcop.23053
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- poruchy spojené s užíváním psychoaktivních látek * epidemiologie MeSH
- prevalence MeSH
- průzkumy a dotazníky MeSH
- rizikové faktory MeSH
- uvěznění MeSH
- vězni * statistika a číselné údaje MeSH
- věznice statistika a číselné údaje MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
Substance use is a global phenomenon that is particularly affecting the prison population. This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. Individual data collection was carried out between 2014 and 2018 with a model European Questionnaire on Drug Use among people in prison. A total of 12,918 people living in prison filled in the survey. People in prison report higher level of drug use when compared with the general population and the use of drug inside prison exist, although at lower levels when compared with predetention. Prisons can represent a point of access to engage individuals who use drugs in interventions that address drug use and risk factors related to both drug use and imprisonment.
Addiction Monitoring Unit Centre for Disease Prevention and Control of Latvia Riga Latvia
Department of Addictology 1st Medical Faculty of the Charles University Prague Czech Republic
Directorate of Epidemiology and Public Health Sciensano Brussels Belgium
Drug Tobacco and Alcohol Control Department Vilnius Lithuania
European Monitoring Centre for Drugs and Drug Addiction Lisbon Portugal
Institute for Social and Political Sciences Lisbon University Portugal
Institute of Psychiatry and Neurology Warsaw Poland
Institute on Drugs and Drug Addiction Lisbon Portugal
Monitoring Centre for Drugs and Drug Addiction National Addiction Authority Strovolos Cyprus
National Center for Prevention of Addictions Warsaw Poland
National Institute of Public Health Ljubljana Slovenia
National Monitoring Centre for Drugs and Addictions Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003756
- 003
- CZ-PrNML
- 005
- 20250206104657.0
- 007
- ta
- 008
- 250121s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jcop.23053 $2 doi
- 035 __
- $a (PubMed)37172289
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Montanari, Linda $u European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal
- 245 10
- $a Prevalence of drug use before and during imprisonment in seven European countries (2014-2018) / $c L. Montanari, L. Royuela, S. Mazzilli, L. Vandam, E. Alvarez, N. Llorens, L. Carapinha, K. Grohmannova, L. Isajeva, L. Ignataviciute, I. Kvaternik, J. Sierosławski, A. Malczewski, E. Plettinckx, R. Sendino, A. Torres, I. Yasemi, L. Tavoschi, V. Mravcik
- 520 9_
- $a Substance use is a global phenomenon that is particularly affecting the prison population. This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. Individual data collection was carried out between 2014 and 2018 with a model European Questionnaire on Drug Use among people in prison. A total of 12,918 people living in prison filled in the survey. People in prison report higher level of drug use when compared with the general population and the use of drug inside prison exist, although at lower levels when compared with predetention. Prisons can represent a point of access to engage individuals who use drugs in interventions that address drug use and risk factors related to both drug use and imprisonment.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a poruchy spojené s užíváním psychoaktivních látek $x epidemiologie $7 D019966
- 650 12
- $a vězni $x statistika a číselné údaje $7 D011329
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a věznice $x statistika a číselné údaje $7 D011330
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a uvěznění $7 D000097787
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Royuela, Luis $u European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal
- 700 1_
- $a Mazzilli, Sara $u Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy $u Scuola Normale Superiore, Pisa, Italy $1 https://orcid.org/0000000279890661
- 700 1_
- $a Vandam, Liesbeth $u European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal
- 700 1_
- $a Alvarez, Elena $u Government Delegation for the National Plan on Drugs, Ministry of Health, Consumer Affairs and Wellbeing, Madrid, Spain
- 700 1_
- $a Llorens, Noelia $u Government Delegation for the National Plan on Drugs, Ministry of Health, Consumer Affairs and Wellbeing, Madrid, Spain
- 700 1_
- $a Carapinha, Ludmila $u Institute on Drugs and Drug Addiction, Lisbon, Portugal
- 700 1_
- $a Grohmannova, Katerina $u National Monitoring Centre for Drugs and Addictions, Prague, Czech Republic $u Department of Addictology, 1st Medical Faculty of the Charles University, Prague, Czech Republic
- 700 1_
- $a Isajeva, Laura $u Addiction Monitoring Unit, Centre for Disease Prevention and Control of Latvia, Riga, Latvia
- 700 1_
- $a Ignataviciute, Lina $u Drug, Tobacco, and Alcohol Control Department, Vilnius, Lithuania
- 700 1_
- $a Kvaternik, Ines $u National Institute of Public Health, Ljubljana, Slovenia
- 700 1_
- $a Sierosławski, Janusz $u Institute of Psychiatry and Neurology, Warsaw, Poland
- 700 1_
- $a Malczewski, Artur $u National Center for Prevention of Addictions, Warsaw, Poland
- 700 1_
- $a Plettinckx, Els $u Directorate of Epidemiology and Public Health, Sciensano, Brussels, Belgium
- 700 1_
- $a Sendino, Rosario $u Government Delegation for the National Plan on Drugs, Ministry of Health, Consumer Affairs and Wellbeing, Madrid, Spain
- 700 1_
- $a Torres, Analia $u Institute for Social and Political Sciences, Lisbon University, Portugal
- 700 1_
- $a Yasemi, Ioanna $u Monitoring Centre for Drugs and Drug Addiction, National Addiction Authority, Strovolos, Cyprus
- 700 1_
- $a Tavoschi, Lara $u Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
- 700 1_
- $a Mravcik, Viktor $u National Monitoring Centre for Drugs and Addictions, Prague, Czech Republic $u Department of Addictology, 1st Medical Faculty of the Charles University, Prague, Czech Republic $u Spolecnost Podane ruce, Brno, Czech Republic
- 773 0_
- $w MED00008005 $t Journal of community psychology $x 1520-6629 $g Roč. 52, č. 8 (2024), s. 1015-1030
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37172289 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104653 $b ABA008
- 999 __
- $a ok $b bmc $g 2263500 $s 1239763
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 52 $c 8 $d 1015-1030 $e 20230512 $i 1520-6629 $m Journal of community psychology $n J Community Psychol $x MED00008005
- LZP __
- $a Pubmed-20250121